Zeitschrift Für Orthomolekulare Medizin · Jul 2026
Berberine – Updates in Diabetology and Longevity Research
By Gröber U, Schütz B
Around 9 million people in Germany live with diagnosed type 2 diabetes, with a high number of undiagnosed cases presumed. Current treatment for type 2 diabetes includes lifestyle interventions and pharmacological interventions with oral antidiabetic drugs and/or subcutaneous insulin injections. At the same time, secondary plant compounds, such as the isoquinoline alkaloid berberine, are attracting increasing attention as therapeutic options. It exhibits a broad spectrum of pharmacological effects, including blood glucose-lowering and blood lipid-lowering properties. Due to its cytoprotective and metabolome-regulating properties, it also plays a role in longevity research. Recent study findings underscore the potential of berberine in numerous chronic age-associated degenerative diseases.